Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Sara Patruno"'
Autor:
Domenico Mattoscio, Elisa Isopi, Alessia Lamolinara, Sara Patruno, Alessandro Medda, Federica De Cecco, Susanna Chiocca, Manuela Iezzi, Mario Romano, Antonio Recchiuti
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 40, Iss 1, Pp 1-16 (2021)
Abstract Background Innovative therapies to target tumor-associated neutrophils (PMN) are of clinical interest, since these cells are centrally involved in cancer inflammation and tumor progression. Resolvin D1 (RvD1) is a lipid autacoid that promote
Externí odkaz:
https://doaj.org/article/2300bda3ff0941f4ba6513b2448e9b84
Publikováno v:
Stem Cells Translational Medicine, Vol 8, Iss 10, Pp 992-998 (2019)
Summary Accumulating evidence indicates that stem cells (SCs) possess immunomodulatory, anti‐inflammatory, and prohealing properties. The mechanisms underlying these functions are being investigated with the final goal to set a solid background for
Externí odkaz:
https://doaj.org/article/0a8d424954f041c5a6dd2023fdb2fdb3
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2020)
Despite the high expectations associated with the recent introduction of CFTR modulators, airway inflammation still remains a relevant clinical issue in cystic fibrosis (CF). The classical anti-inflammatory drugs have shown very limited efficacy, whe
Externí odkaz:
https://doaj.org/article/fed3bcba42bb46b2874c7d0da6ad2b30
Autor:
Elisa Isopi, Domenico Mattoscio, Marilina Codagnone, Veronica Cecilia Mari, Alessia Lamolinara, Sara Patruno, Marco D’Aurora, Eleonora Cianci, Annalisa Nespoli, Sara Franchi, Valentina Gatta, Marc Dubourdeau, Paolo Moretti, Maria Di Sabatino, Manuela Iezzi, Mario Romano, Antonio Recchiuti
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Non-resolving lung inflammation and Pseudomonas aeruginosa infections are the underlying cause of morbidity and mortality in cystic fibrosis (CF). The endogenous lipid mediator resolvin (Rv) D1 is a potent regulator of resolution, and its roles, acti
Externí odkaz:
https://doaj.org/article/936a8995b9d341228266da159d14c588
Publikováno v:
Frontiers in Pharmacology, Vol 9 (2018)
Resolution Pharmacology identifies drugs developed on the biology of the resolution phase of inflammation, the complex molecular and cellular network of events that ensure the tight temporal and spatial control on the inflammatory response. As such,
Externí odkaz:
https://doaj.org/article/ad9edac81c824f6f804421c714432708
Autor:
Alessia Lamolinara, Manuela Iezzi, Sara Patruno, Federica De Cecco, Susanna Chiocca, Mario R. Romano, Elisa Isopi, Antonio Recchiuti, Domenico Mattoscio, Alessandro Medda
Publikováno v:
Journal of Experimental & Clinical Cancer Research : CR
Journal of Experimental & Clinical Cancer Research, Vol 40, Iss 1, Pp 1-16 (2021)
Journal of Experimental & Clinical Cancer Research, Vol 40, Iss 1, Pp 1-16 (2021)
Background Innovative therapies to target tumor-associated neutrophils (PMN) are of clinical interest, since these cells are centrally involved in cancer inflammation and tumor progression. Resolvin D1 (RvD1) is a lipid autacoid that promotes resolut
Autor:
Manuela Iezzi, Mario R. Romano, Domenico Mattoscio, A. Pomilio, Elisa Isopi, Alessia Lamolinara, Antonio Recchiuti, Romina Pecce, Sara Patruno
Publikováno v:
The FASEB Journal
An excessive, non‐resolving inflammatory response underlies severe COVID‐19 that may have fatal outcomes. Therefore, the investigation of endogenous pathways leading to resolution of inflammation is of interest to uncover strategies for mitigatin
Autor:
Romina Pecce, Sara Patruno, Domenico Mattoscio, Antonio Recchiuti, Elisa Isopi, Alessia Lamolinara, Mario R. Romano, Manuela Iezzi, A. Pomilio
Resolvins (Rv) are endogenous lipid autacoids that mediate resolution of inflammation and bacterial infections. Their roles in SARS-CoV-2 and COVID-19 are of considerable interest in the context of cystic fibrosis (CF) given the paucity of data regar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::425a2ce7c6339ea9e4ec36dcdfccb988
https://doi.org/10.1101/2020.08.28.255463
https://doi.org/10.1101/2020.08.28.255463
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2020)
Frontiers in Pharmacology
Frontiers in Pharmacology
Despite the high expectations associated with the recent introduction of CFTR modulators, airway inflammation still remains a relevant clinical issue in cystic fibrosis (CF). The classical anti-inflammatory drugs have shown very limited efficacy, whe
Autor:
Marc Dubourdeau, Marco D'Aurora, Veronica Cecilia Mari, Manuela Iezzi, Maria Di Sabatino, Annalisa Nespoli, Sara Franchi, Elisa Isopi, Mario R. Romano, Paolo Moretti, Domenico Mattoscio, Sara Patruno, Eleonora Cianci, Alessia Lamolinara, Valentina Gatta, Marilina Codagnone, Antonio Recchiuti
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Frontiers in Immunology
Frontiers in Immunology
Non-resolving lung inflammation and Pseudomonas aeruginosa infections are the underlying cause of morbidity and mortality in cystic fibrosis (CF). The endogenous lipid mediator resolvin (Rv) D1 is a potent regulator of resolution, and its roles, acti